Company intelligence / Profile preview
Alto Neuroscience
Mountain View, California, United Statesaltoneuroscience.com ↗
- Ownership
- Public · ANRO
- Development stage
- Phase 2
01
Overview
Alto Neuroscience has reported positive interim results from a double-blind Phase IIb trial of ALTO‑300 for major depressive disorder using an EEG biomarker to identify likely responders. The company’s pipeline includes several clinical-stage candidates for depression and schizophrenia. A new Phase II trial of ALTO‑203 began in April 2024 targeting MDD with anhedonia; topline data are expected in the first half of next year. The company leverages its proprietary Precision Psychiatry Platform to match patients with therapies based on brain biomarkers.
- Therapeutic areas
- Psychiatry
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
10 assets9 more assets in the full pipeline.
Request access →03
Financials
- Market cap
- $1.1B
- Total revenue
- $0
- Enterprise value
- $875.1M
Beyond the preview
Go deeper on Alto Neuroscience.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Alto Neuroscience.